TOOKAD

padeliparvovec? (Note: TOOKAD is verteporfin-based vascular-targeted photodynamic therapy). · Steba Biotech S.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TOOKAD, covering 2020-11-13 to 2022-12-07. Get the full timeline:

Most recent: EMA Authorised: Tookad (padeliporfin di-potassium) — STEBA Biotech S.A